Description
This fibrinogen binding peptide has a sequence of EHIPA; it mimic the fibrinogen binding domain of GP IIb/IIIa, preventing fibrinogen-platelet binding; it may exhibit antithrombotic activity.
| Product Unit Size | Cost | Quantity | Stock |
|---|
This fibrinogen binding peptide has a sequence of EHIPA; it mimic the fibrinogen binding domain of GP IIb/IIIa, preventing fibrinogen-platelet binding; it may exhibit antithrombotic activity.
| Purity | ≥98% |
|---|---|
| Formula | C25H39H7O8 |
| Formula Wt. | 565.63 |
| Synonym | EHIPA. |
| Solubility | Soluble in water (2 mg/mL). |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| Info Sheet |
|---|
Gartner TK, Loudon R, Taylor DB. The peptides APLHK, EHIPA and GAPL are hydropathically equivalent peptide mimics of a fibrinogen binding domain of glycoprotein IIb/IIIa. Biochem Biophys Res Commun. 1991 Nov 14;180(3):1446-52. PMID: 1953789.
STING antagonist
Pt-based DNA cross-linker.
CDK4/6 inhibitor.
Vitamin B, required for formation of NAD and NA...
Cyclic tetrapeptide; HDAC inhibitor.
Inhibitor of coronaviruses
Dual inhibitor of PI3K and mTOR.
Src and Abl inhibitor.
BHA derivative, cellular differentiation induce...
Mycotoxin contaminant found in cereal grains.
HDAC inhibitor.
Aminopeptidase inhibitor.
BCL-XL specific degrader
Synthetic steroid; glucocorticoid agonist.
Hydroxycinnamic acid found in coffee, argan oil...
AhR agonist, dihydroorotate dehydrogenase inhib...
Potential p53 activator or SIRT2 inhibitor.
Statin; HMG-CoA reductase inhibitor.
Inhibitor of EGFR, HER2, and HER3.
Thienylbutyl ITC analog.